Oberweis Asset Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-170,000	Closed	-$3.11M	–	195
2023 Q3	$3.11M	Buy	170,000 +85,000	+100%	+$1.56M	0.33%	118
2023 Q2	$1.83M	Buy	85,000 +24,695	+41%	+$533K	0.22%	136
2023 Q1	$1.77M	Buy	+60,305	New	+$1.77M	0.27%	123